Okairos' Spinoff / Spinout Round

Okairos raised a round of funding on January 01, 2007. Investors include Merck & Co..

Okairos is a clinical-stage biopharmaceutical company, developing genetic vaccines for major infectious diseases - including malaria, hepatitis C, HIV, respiratory syncytial virus and cancer - using a…

Articles about Okairos' Spinoff / Spinout Round: